Indication
Hypertension and Dyslipidemia
10 clinical trials
12 products
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348(2) With Coadministration of CKD-828, D097 and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2021-07-20
Product
CKD-348(2)Product
CKD-828Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 With Coadministration of CKD-828, D097 and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2021-02-24
Product
CKD-348Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348(5) Compared With Co-administration of CKD-828, D097, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-06-07
Product
CKD-348(5)Product
CKD-386(3)Product
D013Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 With Co-administration of CKD-828, D097, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-11-30
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-386(3) With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-06-06
Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-386 With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-11-27
Product
CKD-386Clinical trial
An Open-label, Randomized, Single-dose, 2-sequence, 4-period, Cross-over, Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-331 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-06-23
Product
CKD-331Product
EX5619Product
CKD-348(3)Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348(3) With Coadministration of CKD-828, D097 and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-05-08
Product
CKD-386(5)Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and the Tolerability of CKD-386(5) With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-09-01
Product
Fimasartan + StatinsClinical trial
A Multi-center, Prospective Observational Study to Evaluate the Effectiveness of a Combination Drug Including Fimasartan and Statins in Patients With Hypertension and DyslipidemiaStatus: Completed, Estimated PCD: 2021-11-03